Physician Photo

Vikram Deshpande, MBBS

Associate Pathologist, Massachusetts General Hospital

Associate Professor of Pathology, Harvard Medical School

Dr. Deshpande has contributed important work for establishing diagnostic criteria, and pioneering new treatments for IgG-4-related disease.

Departments
Department of Pathology

Specialties

  • Cancer Center
  • Sarcoma and Connective Tissue Oncology
Clinical Interests
Gastrointestinal (GI) pathology
Bone and Soft Tissue Pathology
Locations
Boston: Massachusetts General Hospital
Medical Education
MBBS, Jawaharlal Institute, University of Pondicherry
Residency, All India Institute of Medical Sciences
Residency, Henry Ford Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Anatomic Pathology & Clinical Pathology, American Board of Pathology
Cytopathology, American Board of Pathology
Gender
Male
Patient Age Group
Adult
Accepting New Patients
Yes

Biography

Dr. Deshpande is a member of the Gastrointestinal Pathology Unit. His research has focused on surgical pathology in the areas of gastrointestinal and connective tissue diseases. His contributions to the field of IgG4-related disease have been instrumental in establishing diagnostic criteria, as well as pioneering new treatments for this disease. Dr. Deshpande has published over 100 peer-reviewed articles, editorials, reviews and book chapters and has been an invited speaker at major national and international pathology meetings. Dr. Deshpande serves on the editorial boards of the Archives of Pathology and Laboratory Medicine, and Diagnostic Histopathology.

Research

Resarch interests include:

  • The pathology and biology of pancreatic tumors
  • IgG4-related disease.

Publications

View my most recent publications at PubMed

  1. IgG4 Related Disease of the Head and Neck. Deshpande VHead Neck Pathol. 2015 Mar 25. [Epub ahead of print]
  2. Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesy N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V. Ann Surg Oncol. 2015 Mar 19. [Epub ahead of print] No abstract available.
  3. YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression. Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA, Nagle JM, Perera RM, Lapouge M, Deshpande V, Zhu AX, Lai A, Min B, Hoshida Y, Avruch J, Sia D, Campreci?s G, McClatchey AI, Llovet JM, Morrissey D, Raj L, Bardeesy N. Cell Rep. 2015 Mar 10. pii: S2211-1247(15)00173-4. doi: 10.1016/j.celrep.2015.02.027. [Epub ahead of print]

Pathology Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-2967
Fax: 617-726-5915